BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, and Henry Schein, Inc. (NASDAQ: HSIC), the largest provider of healthcare products and services to office-based practitioners in the combined North American and European markets, announced today the signing of an exclusive, multi-year distribution agreement under which the BIOLASE direct sales and service organizations will collaborate with Henry Schein in the marketing, sales and service of all professional BIOLASE dental laser system products, including the Waterlase® MD -- the industry’s leading “all-tissue” dental laser system.
